Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K201 for restoration of sinus rhythm in AF
NCT00626652Phase 2Completed
- Sponsor
- Sequel Pharmaceuticals
- Start
- Mar 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of K201 in Atrial fibrillation (AFib), sponsored by Sequel Pharmaceuticals. Started Mar 2008; status: completed.
02
Drugs
K201
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00626652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00626652.